We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+2.71%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$769M
AUM Growth
+$65.2M
Cap. Flow
+$56.1M
Cap. Flow %
7.29%
Top 10 Hldgs %
20.71%
Holding
282
New
36
Increased
134
Reduced
24
Closed
29

Top Buys

Rank Stock Value
1
DT icon
Dynatrace
DT
+$10.8M
2
CRWD icon
CrowdStrike
CRWD
+$10.4M
3
ZEN
ZENDESK INC
ZEN
+$10.2M
4
DOCU
DocuSign
DOCU
+$9.95M
5
CRM icon
Salesforce
CRM
+$8.04M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$11.7M
2
ANSS
Ansys
ANSS
+$9.54M
3
QRVO icon
Qorvo
QRVO
+$9.26M
4
SPGI icon
S&P Global
SPGI
+$8.81M
5
MKTX icon
MarketAxess Holdings
MKTX
+$6.51M

Sector Composition

Rank Sector Weight
1 Technology 37.72%
2 Healthcare 10.52%
3 Financials 7.64%
4 Industrials 7.46%
5 Communication Services 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPWK icon
151
Upwork
UPWK
$1.09B
$574K 0.07%
+12,748
New +$621K
ZG icon
152
Zillow
ZG
$7.02B
$574K 0.07%
+6,510
New +$664K
ADPT icon
153
Adaptive Biotechnologies
ADPT
$3.56B
$568K 0.07%
+16,697
New +$604K
RNG icon
154
RingCentral
RNG
$4.05B
$562K 0.07%
+2,585
New +$655K
APPN icon
155
Appian
APPN
$1.74B
$556K 0.07%
+6,012
New +$666K
EXAS
156
DELISTED
Exact Sciences
EXAS
$547K 0.07%
+5,727
New +$605K
QTRX icon
157
Quanterix
QTRX
$173M
$534K 0.07%
+10,717
New +$552K
IJH icon
158
iShares Core S&P Mid-Cap ETF
IJH
$123B
$467K 0.06%
8,885
-2,020
-19% -$109K
NVCR icon
159
NovoCure
NVCR
$2.04B
$466K 0.06%
+4,013
New +$607K
RDFN
160
DELISTED
Redfin
RDFN
$439K 0.06%
+8,763
New +$474K
DCPH
161
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$420K 0.05%
+12,349
New +$394K
ZGNX
162
DELISTED
Zogenix, Inc.
ZGNX
$400K 0.05%
+26,320
New +$411K
BIV icon
163
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$390K 0.05%
4,134
+295
+8% +$26.7K
VEA icon
164
Vanguard FTSE Developed Markets ETF
VEA
$226B
$362K 0.05%
7,165
-1,561
-18% -$81.2K
BX icon
165
Blackstone
BX
$104B
$349K 0.05%
3,000
ACN icon
166
Accenture
ACN
$89.9B
$314K 0.04%
980
PG icon
167
Procter & Gamble
PG
$343B
$297K 0.04%
2,128
+2
+0.1% +$283
XNTK icon
168
State Street SPDR NYSE Technology ETF
XNTK
$2.06B
$292K 0.04%
1,953
VTI icon
169
Vanguard Total Stock Market ETF
VTI
$654B
$278K 0.04%
1,254
+200
+19% +$45.6K
IART icon
170
Integra LifeSciences
IART
$1.54B
$274K 0.04%
4,000
KO icon
171
Coca-Cola
KO
$354B
$262K 0.03%
5,000
IJR icon
172
iShares Core S&P Small-Cap ETF
IJR
$109B
$260K 0.03%
2,384
-48
-2% -$5.29K
ELV icon
173
Elevance Health
ELV
$81.9B
$254K 0.03%
682
GOOG icon
174
Alphabet (Google) Class C
GOOG
$3.9T
$245K 0.03%
1,840
-540
-23% -$74.5K
SXT icon
175
Sensient Technologies
SXT
$5.4B
$243K 0.03%
2,667

Similar funds

Stanley-Laman Group's Q3 2021 Portfolio in Review

As of Q3 2021, Stanley-Laman Group held 282 positions worth $769M, up 9.3% from $703M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Stanley-Laman Group deployed $56.1M of net new capital in Q3 2021, opening 36 new positions and adding to 134 existing holdings. Its largest new stake was ZENDESK INC: 79,007 shares worth $9.2M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $11.7M trimmed.

  • Stanley-Laman Group's largest Q3 2021 buy was ZENDESK INC: 79,007 shares worth $9.2M.
  • Stanley-Laman Group added most to Dynatrace in Q3 2021, an estimated $10.8M increase.
  • Stanley-Laman Group's biggest Q3 2021 reduction was Advanced Micro Devices, cutting an estimated $11.7M.
  • Stanley-Laman Group fully exited Ansys in Q3 2021, selling an estimated $9.54M.
  • Stanley-Laman Group's ten largest holdings make up 21% of its $769M portfolio in Q3 2021.
  • Stanley-Laman Group opened 36 new positions and closed 29 in Q3 2021.
  • Stanley-Laman Group's portfolio value rose 9.3% quarter-over-quarter to $769M.

Based on Stanley-Laman Group's 13F filing for Q3 2021, filed 3 Nov 2021.